Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat
Mortensen MB, Nordestgaard BG
JAMA Cardiol. Pub. online 2 October 2019
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Alexander M, Loomis AK, van der Lei J, et al.
BMJ. 2019;367:l5367
Leggi
Small HDL particles are associated with gestational diabetes, providing a potential early identification tool
Fernandez ML
J Nutr. Pub. online 4 October 2019
Leggi
Chronic kidney disease diagnosis and management – A review
Chen TK, Knicely DH, Grams ME
JAMA. 2019;322(13):1294-304
Leggi
Treatment of adolescent obesity in 2020
Cardel MI, Jastreboff AM, Kelly AS
JAMA. Pub. online September 30, 2019
Leggi
Primary prevention of cardiovascular disease
Jain A, Davis AM
JAMA. Pub. online October 4, 2019
Leggi
Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China
Wei Y, Xu Q, Yang H, et al.
PLOS Medicine. Pub. online October 1, 2019
Leggi
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray JJV, Solomon SD, Inzucchi SE, et al.
NEJM. Pub. online 19 September 2019
Leggi
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure
Ghosh RK, Gupta M, Bandyopadhyay D, et al.
The American Journal of Cardiology. Pub. online 9 September 2019
Leggi
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes – The CAROLINA Randomized Clinical Trial
Rosenstock J, Kahn SE, Johansen OE, et al.
JAMA. 2019;322(12):1155-66
Leggi